Companies / Medicinova Inc

Medicinova Inc

Nasdaq: MNOVCIK 1226616LA JOLLA, CA

Financials · FY2025

Revenue$409.7K
Net income$-12.00M
Total debt$0
Cash$25.42M
Diluted EPS$-0.24
Shares outstanding49.2M

Ownership

49.2M shares outstanding · as of May 12, 2026
10.7%Institutions
Ownership
Institutions10.69%5,263,523
Public float89.31%43,957,723

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 5

View all →
Insider% of sharesShares
Beaver CarolynDirector
——
Iwaki YuichiCEOPresident and CEO
——
Lemerond NicoleDirector
——
Matsuda KazukoChief Medical Officer
——
Nagao HidekiDirector
——

Institutional holders 33

View all →
HolderValue% of shares
Essex Woodlands Management, Inc.$1.45M2.25%
BlackRock, Inc.$992.8K1.53%
Vanguard Group Inc$924.4K1.43%
Citigroup Inc$832.8K1.29%
DRW Securities, LLC$820.8K<0.01%
Geode Capital Management, LLC$745.3K1.10%
UBS Group AG$295.6K0.46%
Renaissance Technologies LLC$260.2K0.39%
State Street Corporation$255.7K0.39%
Jane Street Group, LLC$213.7K0.33%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jun 23, 2026Nagao Hideki
Director
GrantStock Option (Right to Buy)—+45K
44,500
0.09% of shares
low
Jun 23, 2026Lemerond Nicole
Director
GrantStock Option (Right to Buy)—+45K
44,500
0.09% of shares
low
Jun 23, 2026Beaver Carolyn
Director
GrantStock Option (Right to Buy)—+45K
44,500
0.09% of shares
low
Jan 16, 2026Matsuda Kazuko
Executive
GrantEmployee Stock Option (Right to Buy)—+350K
350,000
0.71% of shares
low
Jan 16, 2026Iwaki Yuichi
CEO
GrantEmployee Stock Option (Right to Buy)—+450K
450,000
0.91% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
MNOVCommon StockEquity58468P206BBG000RDP030